Tailoring of Medical Treatment: Hemostasis and Thrombosis Towards Precision Medicine

Overview

Journal Haematologica

Specialty Hematology

Date 2017 Mar 3

PMID 28250003

Citations 5

Authors

Giovanni Di Minno

Elena Tremoli

Affiliations

Soon will be listed here.

Citing Articles

Next-generation strategies to improve safety and efficacy of adeno-associated virus-based gene therapy for hemophilia: lessons from clinical trials in other gene therapies.

Di Minno G, Miesbach W, Castaman G, Peyvandi F Haematologica. 2024; 109(12):3879-3891.

PMID: 38450517 PMC: 11609791. DOI: 10.3324/haematol.2023.284622.

Digital Personal Health Coaching Platform for Promoting Human Papillomavirus Infection Vaccinations and Cancer Prevention: Knowledge Graph-Based Recommendation System.

Ammar N, Olusanya O, Melton C, Chinthala L, Huang X, White B JMIR Form Res. 2023; 7:e50210.

PMID: 37966885 PMC: 10687687. DOI: 10.2196/50210.

Challenges in Metabolomics-Based Tests, Biomarkers Revealed by Metabolomic Analysis, and the Promise of the Application of Metabolomics in Precision Medicine.

Di Minno A, Gelzo M, Caterino M, Costanzo M, Ruoppolo M, Castaldo G Int J Mol Sci. 2022; 23(9).

PMID: 35563604 PMC: 9103094. DOI: 10.3390/ijms23095213.

Integrated Hemophilia Patient Care via a National Network of Care Centers in the United States: A Model for Rare Coagulation Disorders.

Valentino L, Baker J, Butler R, Escobar M, Frick N, Karp S J Blood Med. 2021; 12:897-911.

PMID: 34707421 PMC: 8544265. DOI: 10.2147/JBM.S325031.

Prophylaxis of venous thromboembolism in Internal Medicine Units: the RAMs issue.

Tufano A, Di Minno G Intern Emerg Med. 2018; 13(4):463-465.

PMID: 29541919 DOI: 10.1007/s11739-018-1829-7.

References

Pipe S . The hope and reality of long-acting hemophilia products. Am J Hematol. 2012; 87 Suppl 1:S33-9. DOI: 10.1002/ajh.23146. View

Angiolillo D . Variability in responsiveness to oral antiplatelet therapy. Am J Cardiol. 2009; 103(3 Suppl):27A-34A. DOI: 10.1016/j.amjcard.2008.11.020. View

Onarheim K, Iversen J, Bloom D . Economic Benefits of Investing in Women's Health: A Systematic Review. PLoS One. 2016; 11(3):e0150120. PMC: 4814064. DOI: 10.1371/journal.pone.0150120. View

Garraway L, Lander E . Lessons from the cancer genome. Cell. 2013; 153(1):17-37. DOI: 10.1016/j.cell.2013.03.002. View

Pitt G . Cardiovascular precision medicine: hope or hype?. Eur Heart J. 2015; 36(29):1842-3. DOI: 10.1093/eurheartj/ehv226. View

Bayer R, Galea S . Public Health in the Precision-Medicine Era. N Engl J Med. 2015; 373(6):499-501. DOI: 10.1056/NEJMp1506241. View

Mega J, Close S, Wiviott S, Man M, Duvvuru S, Walker J . PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes. J Thromb Thrombolysis. 2015; 41(3):374-83. DOI: 10.1007/s11239-015-1264-9. View

Altman R . PharmGKB: a logical home for knowledge relating genotype to drug response phenotype. Nat Genet. 2007; 39(4):426. PMC: 3203536. DOI: 10.1038/ng0407-426. View

Shah S, Arnett D, Houser S, Ginsburg G, MacRae C, Mital S . Opportunities for the Cardiovascular Community in the Precision Medicine Initiative. Circulation. 2016; 133(2):226-31. DOI: 10.1161/CIRCULATIONAHA.115.019475. View

10.

Sofi F, Marcucci R, Gori A, Giusti B, Abbate R, Gensini G . Clopidogrel non-responsiveness and risk of cardiovascular morbidity. An updated meta-analysis. Thromb Haemost. 2010; 103(4):841-8. DOI: 10.1160/TH09-06-0418. View

11.

Hughes T, Kaeda J, Branford S, Rudzki Z, Hochhaus A, Hensley M . Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia. N Engl J Med. 2003; 349(15):1423-32. DOI: 10.1056/NEJMoa030513. View

12.

Bhatt D, Pare G, Eikelboom J, Simonsen K, Emison E, Fox K . The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study. Eur Heart J. 2012; 33(17):2143-50. DOI: 10.1093/eurheartj/ehs059. View

13.

Davies H, Bignell G, Cox C, Stephens P, Edkins S, Clegg S . Mutations of the BRAF gene in human cancer. Nature. 2002; 417(6892):949-54. DOI: 10.1038/nature00766. View

14.

Inzucchi S, Bergenstal R, Buse J, Diamant M, Ferrannini E, Nauck M . Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2012; 55(6):1577-96. DOI: 10.1007/s00125-012-2534-0. View

15.

Shaw J, Cooper M . Guidelines and their use in clinical practice. Diab Vasc Dis Res. 2013; 11(1):3-4. DOI: 10.1177/1479164113515372. View

16.

Kurnik K, Kreuz W, Horneff S, During C, Schobess R, Bidlingmaier C . Effects of the factor V G1691A mutation and the factor II G20210A variant on the clinical expression of severe hemophilia A in children--results of a multicenter studys. Haematologica. 2007; 92(7):982-5. DOI: 10.3324/haematol.11161. View

17.

Vohra S . N-of-1 trials to enhance patient outcomes: identifying effective therapies and reducing harms, one patient at a time. J Clin Epidemiol. 2016; 76:6-8. DOI: 10.1016/j.jclinepi.2016.03.028. View

18.

Huser V, Sincan M, Cimino J . Developing genomic knowledge bases and databases to support clinical management: current perspectives. Pharmgenomics Pers Med. 2014; 7:275-83. PMC: 4175027. DOI: 10.2147/PGPM.S49904. View

19.

Di Minno M, Iervolino S, Soscia E, Tosetto A, Coppola A, Schiavulli M . Magnetic resonance imaging and ultrasound evaluation of "healthy" joints in young subjects with severe haemophilia A. Haemophilia. 2013; 19(3):e167-73. DOI: 10.1111/hae.12107. View

20.

Krasopoulos G, Brister S, Beattie W, Buchanan M . Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis. BMJ. 2008; 336(7637):195-8. PMC: 2213873. DOI: 10.1136/bmj.39430.529549.BE. View